Aggressive fibromatosis in giant retroperitoneal tumor
Keywords:
aggressive fibromatosis, retroperitoneal tumor, desmoid tumor, chemotherapy, surgery., aggressive fibromatosis, retroperitoneal tumor, desmoid tumorAbstract
Retroperitoneal fibromatosis is an aggressive fibromatosis of slow and progressive installation, and currently there are discrepancies related to its optimal treatment. We present the case of a female patient of 30 years old with a history of bronchial asthma, which was studied in 2011 for abdominal pain, gastric fullness, and increased abdominal perimeter. A large tumor mass was diagnosed that involved abdominal organs and large vessels. In the case of retroperitoneal fibromatosis, surgery was performed twice, without resecting the tumor. With the confirmation by biopsy of an aggressive fibromatosis, it´s proposed by Oncology Service (January 2012), the use of chemotherapy with anthracyclines in neo-adjuvant setting, obtaining an objective response at the end of six cycles, achieving the resection of 80% of the tumor. Subsequently, he remained with hormone therapy (tamoxifen-20mg/day), and at the end of 4 months, another surgical intervention was performed, obtaining a complete resection of the residual tumor disease. It is maintained to date, in follow-up consultation by Oncology, with a satisfactory evolution, asymptomatic, and without clinical or imaging evidence of fibromatosis.
Downloads
References
Fisher C, Thway K. Aggressive fibromatosis. Pathology. 2014; 46:135-140. PubMed: PMID:24378386.
Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Intra-abdominal fibromatosis: a pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol. 1990; 14: 335-341. PubMed: PMID: 2321698.
Casillas J, Sais GJ, Greve JL, Iparraguirre MC, Morillo G. Imaging of intra- and extraabdominal desmoid tumors. RadioGraphics. 1991; 11: 959-68. PubMed: PMID: 1749859.
Baron RL, Lee JK. Mesenteric desmoid tumors: sonographic and computed-tomographic appearance. Radiology. 1981; 140: 777-9. PubMed: PMID: 7280249.
Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RK. Extra-abdominal fibromatosis (extra-abdominal desmoid fibromatosis). In: Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RK, eds. Atlas of tumor pathology. I. Tumors of the soft tissues. Washington, DC: Armed Forces Institute of Pathology, 2011: 71-87.
Sheth S, Horton KM, Garland MR, Fishman EK. Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis. Radiographics. 2003; 23: 457-73. PubMed: PMID: 12640160.
Nuyttens JJ, Rust PF, Thomas CR, Turrisi AT. Surgery versus radiation therapy for patients with aggressive fibromatosisor desmoid tumors: A comparative review of 22articles. Cancer. 2000; 88: 1517-1523. PubMed: PMID: 10738207.
Shields CJ, Winter DC, Kirwan WO et al. Desmoid tumours. Eur J Surg Oncol. 2001; 27: 701-706. PubMed: PMID: 11735163.
Alman BA, Pajerski ME, Díaz-Cano S, Corboy K, Wolfe HJ: Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol. 1997; 6: 98-101. PubMed: PMID: 9098648.
De Marchis ML, Tonelli F, Quaresmini D, Lovero D, Della-Morte D, Silvestris F, et al. Desmoid Tumors in Familial Adenomatous Polyposis. Anticancer Res. 2017; 37(7): 3357-3366. PubMed: PMID: 28668823.
Hosalkar HS, Torbert JT, Fox EJ, Delaney TF, Aboulafia AJ, Lackman RD. Musculoskeletal desmoid tumors. J Am Acad Orthop Surg. 2008; 16: 188-198. PubMed: PMID: 18390481.
Garbay D, Le Cesne A, Penel N, Chevreau C, Marec-Berard P, Blay JY, et al. Chemotherapy in patients with desmoids tumors: a study from French Sarcoma Group (FSG). Ann Oncol. 2012; 23: 182-186. PubMed: PMID:21444357.
Strauss DC, Hayes AJ, Thway K, et al. Surgical management of primary retroperitoneal sarcoma. Br J Surg. 2010; 97: 698-706. PubMed: PMID: 20306527.
El-Haddad M, El-Sebaie M, Ahmad R, Khalil E, Shahin M, Pant R, Memon M, et al. Treatment of aggressive fibromatosis: the experience of a single institution. Clin Oncol (R Coll Radiol). 2009; 21: 775-780. PubMed: PMID: 19875275.
Sorensen A, Seller JO, Nielsen OS, Jensen OM. Aggressiv fibromatose. Ugeskrift for Laeger. 2013; 162: 6676-8. PubMed: PMID:11188054.
Schulz-Ertner D, Zierhut D, Mende U, Harms W, Branitzki P, Wannenmacher M. The role of radiation therapy in the managament of desmoid tumors. Strahlenther Onkol. 2010; 178: 78-83. PubMed: PMID: 11942041.
Krikelis D, Judson I. Role of chemotherapy in the management of soft tissue sarcomas. Expert Rev Anticancer Ther. 2010; 10: 249-260. PubMed: PMID: 20132000.
Corradi D, Maestri R, Palmisano A, et al. Idiopathic retroperitoneal fibromatosis: clinicopathologic features and differential diagnosis. Kidney Int. 2007; 72: 742-753. PubMed: PMID: 17622270.
Sportiello DJ, Hoogerland DL. A recurrent pelvic desmoids tumor successfully treated with tamoxifen. Cancer. 1991; 67: 1443-1446. PubMed: PMID: 1991311.
Spear MA, Jennings LC, Mankin HJ, et al. Individualizing management of aggressive fibromatoses. Int J Radiation Oncology Biol Phys. 1998; 40: 637-45. PubMed: PMID: 9486614.
Grobmyer SR, Wilson JP, Apel B, et al. Recurrent retroperitoneal sarcoma: Impact of biology and therapy on outcomes. J Am Coll Surg. 2010; 210:602-608. PubMed: PMID: 20421013.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).